116 related articles for article (PubMed ID: 22152183)
1. Effect of health-related quality-of-life instrument and quality-adjusted life year calculation method on the number of life years gained in the critical care setting.
Vainiola T; Roine RP; Pettilä V; Kantola T; Räsänen P; Sintonen H
Value Health; 2011 Dec; 14(8):1130-4. PubMed ID: 22152183
[TBL] [Abstract][Full Text] [Related]
2. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
Griebsch I; Coast J; Brown J
Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
[TBL] [Abstract][Full Text] [Related]
3. Cost of a quality-adjusted life year in liver transplantation: the influence of the indication and the model for end-stage liver disease score.
Åberg F; Mäklin S; Räsänen P; Roine RP; Sintonen H; Koivusalo AM; Höckerstedt K; Isoniemi H
Liver Transpl; 2011 Nov; 17(11):1333-43. PubMed ID: 21770017
[TBL] [Abstract][Full Text] [Related]
4. Cost-utility analysis of cataract surgery in the second eye.
Busbee BG; Brown MM; Brown GC; Sharma S
Ophthalmology; 2003 Dec; 110(12):2310-7. PubMed ID: 14644712
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of multilevel hemilaminectomy for lumbar stenosis-associated radiculopathy.
Parker SL; Fulchiero EC; Davis BJ; Adogwa O; Aaronson OS; Cheng JS; Devin CJ; McGirt MJ
Spine J; 2011 Aug; 11(8):705-11. PubMed ID: 21641874
[TBL] [Abstract][Full Text] [Related]
6. Costs and health-related quality of life effects of hysterectomy in patients with benign uterine disorders.
Taipale K; Leminen A; Räsänen P; Heikkilä A; Tapper AM; Sintonen H; Roine RP
Acta Obstet Gynecol Scand; 2009; 88(12):1402-10. PubMed ID: 19900067
[TBL] [Abstract][Full Text] [Related]
7. Survival and outcome of neurosurgical patients requiring ventilatory support after intensive care unit stay.
Malmivaara K; Hernesniemi J; Salmenperä R; Ohman J; Roine RP; Siironen J
Neurosurgery; 2009 Sep; 65(3):530-7; discussion 537-8. PubMed ID: 19687698
[TBL] [Abstract][Full Text] [Related]
8. Cost-utility of routine cataract surgery.
Räsänen P; Krootila K; Sintonen H; Leivo T; Koivisto AM; Ryynänen OP; Blom M; Roine RP
Health Qual Life Outcomes; 2006 Sep; 4():74. PubMed ID: 17010185
[TBL] [Abstract][Full Text] [Related]
9. Community or patient preferences for cost-effectiveness of cardiac rehabilitation: does it matter?
Oldridge N; Furlong W; Perkins A; Feeny D; Torrance GW
Eur J Cardiovasc Prev Rehabil; 2008 Oct; 15(5):608-15. PubMed ID: 18800005
[TBL] [Abstract][Full Text] [Related]
10. Not all "quality-adjusted life years" are equal.
Marra CA; Marion SA; Guh DP; Najafzadeh M; Wolfe F; Esdaile JM; Clarke AE; Gignac MA; Anis AH
J Clin Epidemiol; 2007 Jun; 60(6):616-24. PubMed ID: 17493521
[TBL] [Abstract][Full Text] [Related]
11. Long-term survival, quality of life, and quality-adjusted life-years among critically ill elderly patients.
Kaarlola A; Tallgren M; Pettilä V
Crit Care Med; 2006 Aug; 34(8):2120-6. PubMed ID: 16763517
[TBL] [Abstract][Full Text] [Related]
12. Cost-utility of breast reduction surgery--a prospective study.
Tykkä E; Räsänen P; Tukiainen E; Asko-Seljavaara S; Heikkilä A; Sintonen H; Roine RP
J Plast Reconstr Aesthet Surg; 2010 Jan; 63(1):87-92. PubMed ID: 19036658
[TBL] [Abstract][Full Text] [Related]
13. A value-based medicine cost-utility analysis of idiopathic epiretinal membrane surgery.
Gupta OP; Brown GC; Brown MM
Am J Ophthalmol; 2008 May; 145(5):923-8. PubMed ID: 18329000
[TBL] [Abstract][Full Text] [Related]
14. The value-based medicine comparative effectiveness and cost-effectiveness of penetrating keratoplasty for keratoconus.
Roe RH; Lass JH; Brown GC; Brown MM
Cornea; 2008 Oct; 27(9):1001-7. PubMed ID: 18812762
[TBL] [Abstract][Full Text] [Related]
15. Long-term outcome and quality-adjusted life years after severe sepsis.
Karlsson S; Ruokonen E; Varpula T; Ala-Kokko TI; Pettilä V;
Crit Care Med; 2009 Apr; 37(4):1268-74. PubMed ID: 19242321
[TBL] [Abstract][Full Text] [Related]
16. The burden of ankylosing spondylitis and the cost-effectiveness of treatment with infliximab (Remicade).
Kobelt G; Andlin-Sobocki P; Brophy S; Jönsson L; Calin A; Braun J
Rheumatology (Oxford); 2004 Sep; 43(9):1158-66. PubMed ID: 15226514
[TBL] [Abstract][Full Text] [Related]
17. Prolonged enoxaparin therapy to prevent venous thromboembolism after primary hip or knee replacement. A cost-utility analysis.
Haentjens P; De Groote K; Annemans L
Arch Orthop Trauma Surg; 2004 Oct; 124(8):507-17. PubMed ID: 15365714
[TBL] [Abstract][Full Text] [Related]
18. Assessing utility values in rheumatoid arthritis: a comparison between time trade-off and the EuroQol.
Ariza-Ariza R; Hernández-Cruz B; Carmona L; Dolores Ruiz-Montesinos M; Ballina J; Navarro-Sarabia F;
Arthritis Rheum; 2006 Oct; 55(5):751-6. PubMed ID: 17013822
[TBL] [Abstract][Full Text] [Related]
19. The cost utility of reduction mammaplasty at medium-term follow-up: a prospective study.
Saariniemi KM; Kuokkanen HO; Räsänen P; Sintonen H; Tukiainen EJ
J Plast Reconstr Aesthet Surg; 2012 Jan; 65(1):17-21. PubMed ID: 21873127
[TBL] [Abstract][Full Text] [Related]
20. Health-related quality of life after a drowning incident as a child.
Suominen PK; Vähätalo R; Sintonen H; Haverinen A; Roine RP
Resuscitation; 2011 Oct; 82(10):1318-22. PubMed ID: 21689879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
